Drug lookup
Drug reference

Dicycloverine hydrochloride

Antimuscarinic · Gastrointestinal Antispasmodic

Also known as Dicyclomine hydrochloride

AntimuscarinicGastrointestinal Antispasmodic
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
Not known to be harmful; manufacturer advises use only if essential.
FDA category + note

Mechanism

Dicycloverine hydrochloride exerts an antimuscarinic action, which is less marked than atropine sulfate. It may also possess a direct action on smooth muscle. These actions collectively lead to reduced intestinal motility.

Indications

Symptomatic relief of gastro-intestinal disorders characterised by smooth muscle spasmIrritable bowel syndrome

Dosing

Adult
10–20 mg 3 times a day
Pediatric
Child 6–23 months: 5–10 mg 3–4 times a day, dose to be taken 15 minutes before feeds; Child 2–11 years: 10 mg 3 times a day; Child 12–17 years: 10–20 mg 3 times a day
Max dose
60 mg daily

Contraindications

  • Paralytic ileus

Side effects

Common
Appetite decreasedfatiguethirst
Serious
  • Apnoea (reported in infant exposed via breast milk)

Pregnancy & lactation

Pregnancy

Not known to be harmful; manufacturer advises use only if essential.

Lactation

Avoid—present in milk; apnoea reported in infant.

Related guidelines

Other Antimuscarinic drugs

Ask House about Dicycloverine hydrochloride

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: BNF·Verified: 2026-05-10 · House clinical team